| ViraEpi531 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi532 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi533 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi534 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi535 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi536 | Epstein barr virus (EBV) | Wp | NA | 14296 | 14296 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi537 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | Hyper | 66.66% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi538 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | Hypo | 33.33% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi539 | Epstein barr virus (EBV) | Wp | NA | 14445 | 14445 | Hyper | 66.66% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi540 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Hyper | 100% | Cell line | B lymphocyte culture post 28 day infection | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi541 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | No methylation | 0% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi542 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hypo | 7.69% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi543 | Epstein barr virus (EBV) | Wp | NA | 14015 | 14015 | Hypo | 7.69% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi544 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 92.30% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi545 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 76.92% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi546 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 76.92% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi547 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 84.61% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi548 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 69.23% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi549 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hypo | 23.07% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi550 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | No methylation | 0% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi551 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | No methylation | 0% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi552 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hypo | 23.07% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi553 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hypo | 7.69% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi554 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | intermediate | 61.50% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi555 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Hypo | 30.76% | Cell line | EBH41.2 LCL cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |